Notably, Chen et al. (2020) used tumor acidity-responsive nanoparticle delivery system (NP-siCD47/CCL25) to discharge CCL25 protein and CD47 siRNA in tumors to enhance CD47 targeted immunotherapy. The gene discussed is CD47; the disease is neoplasm.